Biologic effects of various doses of ethinyl estradiol in postmenopausal women
- PMID: 6281707
Biologic effects of various doses of ethinyl estradiol in postmenopausal women
Abstract
To determine which dosage of estrogen might provide physiologic replacement while minimizing adverse effects, 20 postmenopausal women were studied before and after oral administration of ethinyl estradiol. Twenty premenopausal women studied in the early and late follicular phases of the menstrual cycle were presumed to reflect normal physiologic function. Variable responses of the different biochemical and biologic markers to the actions of ethinyl estradiol were observed. Liver protein synthesis was the most sensitive measure of the action of ethinyl estradiol. In comparing the relative potencies of ethinyl estradiol with previously reported results observed with the usage of conjugated equine estrogens, the actions of 10 micrograms ethinyl estradiol were approximately equivalent to the biologic effects of 1.25 mg conjugated estrogens. The results suggest that ethinyl estradiol is far more potent than previously believed and that the daily administration of 10 micrograms, a dose lower than currently available commercial preparations, may be adequate for relief of symptoms of vaginal atrophy and may provide protection from the occurrence of osteoporotic fractures.
Similar articles
-
Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.Am J Obstet Gynecol. 2003 Jan;188(1):92-9. doi: 10.1067/mob.2003.104. Am J Obstet Gynecol. 2003. PMID: 12548201 Clinical Trial.
-
Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.Arzneimittelforschung. 1982;32(7):787-91. Arzneimittelforschung. 1982. PMID: 6289846
-
The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.Clin Pharmacol Ther. 1998 Aug;64(2):204-10. doi: 10.1016/S0009-9236(98)90154-0. Clin Pharmacol Ther. 1998. PMID: 9728901 Clinical Trial.
-
Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.Expert Rev Cardiovasc Ther. 2007 Jul;5(4):777-89. doi: 10.1586/14779072.5.4.777. Expert Rev Cardiovasc Ther. 2007. PMID: 17605655 Review.
-
Optimizing the dose of hormone replacement therapy.Int J Fertil Womens Med. 2002 Sep-Oct;47(5):205-10. Int J Fertil Womens Med. 2002. PMID: 12469707 Review.
Cited by
-
Current status of postmenopausal oestrogen therapy.Drugs. 1987 Feb;33(2):95-106. doi: 10.2165/00003495-198733020-00001. Drugs. 1987. PMID: 3552594 Review. No abstract available.
-
Transdermal estradiol. A review of its pharmacological profile, and therapeutic potential in the prevention of postmenopausal osteoporosis.Drugs Aging. 1992 Nov-Dec;2(6):487-507. doi: 10.2165/00002512-199202060-00005. Drugs Aging. 1992. PMID: 1493353 Review.
-
Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.Drugs. 1990 Oct;40(4):561-82. doi: 10.2165/00003495-199040040-00006. Drugs. 1990. PMID: 2083514 Review.
-
Transdermal estradiol substitution therapy for the induction of puberty in female hypogonadism.J Endocrinol Invest. 1991 Jun;14(6):481-8. doi: 10.1007/BF03346847. J Endocrinol Invest. 1991. PMID: 1774444
-
Clinical opinion: the biologic and pharmacologic principles of estrogen therapy for symptomatic menopause.MedGenMed. 2006 Mar 28;8(1):85. MedGenMed. 2006. PMID: 16915215 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical